Grastin

GRASTEK: Effective Treatment for Grass Pollen Allergies

GRASTEK is a sublingual tablet designed to help manage grass pollen-induced allergic rhinitis and conjunctivitis. This treatment is specifically for individuals who have confirmed positive skin tests or in vitro testing for pollen-specific IgE antibodies related to Timothy grass or cross-reactive grass pollens.

Key Features:

• Indication: GRASTEK is indicated for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis.
• Age Range: Approved for use in persons aged 5 through 65 years.
• Dosage: One tablet should be placed under the tongue daily. Allow the tablet to dissolve completely before swallowing.
• Administration: Initiate treatment at least 12 weeks before the expected onset of each grass pollen season and continue throughout the season. For sustained effectiveness, GRASTEK may be taken daily for three consecutive years.
• Contraindications: GRASTEK may not be suitable for patients with certain underlying medical conditions that could reduce their ability to survive a serious allergic reaction. It is also not recommended for patients who may be unresponsive to epinephrine or inhaled bronchodilators, such as those taking beta-blockers.

Why Choose GRASTEK?

GRASTEK offers a reliable and effective way to manage grass pollen allergies. By using this sublingual immunotherapy, you can reduce symptoms and improve your quality of life during the grass pollen season. Consult with your healthcare provider to determine if GRASTEK is the right treatment for you.